Presentation TCT 2016 What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT Presenter: Freek W.A. Verheugt November 01, 2016 REGISTER for free or LOG IN to view this content Heart Rhythm Presentation TCT 2016 Atrial Fibrillation Up Next Presentation TCT 2016 Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS Presenter: Dominick J. Angiolillo November 01, 2016 More slides + Presentation TCT 2016 European Guidelines on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI Presenter: Davide Capodanno November 01, 2016 Presentation TCT 2016 Case Conclusion: How Did We Treat Our Patient? Presenter: Alberto Menozzi November 01, 2016 We Recommend
Presentation TCT 2016 Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS Presenter: Dominick J. Angiolillo November 01, 2016
Presentation TCT 2016 European Guidelines on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI Presenter: Davide Capodanno November 01, 2016
Presentation TCT 2016 Case Conclusion: How Did We Treat Our Patient? Presenter: Alberto Menozzi November 01, 2016